Shanghai Boyin Biotech Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 2

Shanghai Boyin Biotech General Information

Description

Developer of non-viral vector-based therapies designed for genetic and chronic disease treatment. The company mainly develops non-viral vector gene therapy, focusing on solving the three major pain points of vector capacity limitation, non-repeatable administration, and high production cost in the field, and devoting itself to global gene therapy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 704 No. 781 Cailun Road
  • China Pilot Free Trade Zone
  • Shanghai
  • China
Primary Industry
Biotechnology
Corporate Office
  • Room 704 No. 781 Cailun Road
  • China Pilot Free Trade Zone
  • Shanghai
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Shanghai Boyin Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC 25-May-2025 Completed Generating Revenue
To view Shanghai Boyin Biotech’s complete valuation and funding history, request access »

Shanghai Boyin Biotech Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Frees Fund Venture Capital Minority
Yongkan Investment Venture Capital Minority
To view Shanghai Boyin Biotech’s complete investors history, request access »

Shanghai Boyin Biotech FAQs

  • When was Shanghai Boyin Biotech founded?

    Shanghai Boyin Biotech was founded in 2020.

  • Where is Shanghai Boyin Biotech headquartered?

    Shanghai Boyin Biotech is headquartered in Shanghai, China.

  • What industry is Shanghai Boyin Biotech in?

    Shanghai Boyin Biotech’s primary industry is Biotechnology.

  • Is Shanghai Boyin Biotech a private or public company?

    Shanghai Boyin Biotech is a Private company.

  • What is Shanghai Boyin Biotech’s current revenue?

    The current revenue for Shanghai Boyin Biotech is .

  • Who are Shanghai Boyin Biotech’s investors?

    Frees Fund and Yongkan Investment have invested in Shanghai Boyin Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process